Siduma Therapeutics
New Haven, US · Founded 2021 · Delaware corporation
Founders & leadership
CC
Craig CrewsNamed on SEC filing
RF
Rebecca FreyNamed on SEC filing
TS
Timothy ShannonNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$31.2M disclosed across 1 round · 2021
▶$31.2MraisedNov 2021 · 11 investors · BiotechnologyRule 506(b)
▶$31.2MraisedNov 2021 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig CrewsExecutive Officer, Director
- Rebecca FreyDirector
- Timothy ShannonDirector
- Offering amount
- $31.2M
- Amount sold
- $31.2M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Siduma Therapeutics raised?
- Siduma Therapeutics has disclosed $31.2M raised across 1 round.
- Where is Siduma Therapeutics headquartered?
- Siduma Therapeutics is headquartered in New Haven, US.